Anaphylactic shock with percutalgine.
D000287:Administration, Topical; D000707:Anaphylaxis / Q000139:chemically induced*; D002164:Camphor / Q000009:adverse effects; D003907:Dexamethasone / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology; D006018:Glycols / Q000009:adverse effects; D006801:Humans; D008610:Menthol / Q000009:adverse effects; D009525:Niacin / Q000009:adverse effects; D009824:Ointments / Q000009:adverse effects*; D012457:Salicylamides / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects
D006018:Glycols; D009824:Ointments; D012457:Salicylamides; D012459:Salicylates; D008610:Menthol; D009525:Niacin; D002164:Camphor; D003907:Dexamethasone